Three Motley Fool contributors believe you can. Here's why they think Axsome Therapeutics (NASDAQ: AXSM), Iovance ...

The release of genome-edited rice marks a policy and scientific shift, positioning India to lead biotech-driven farming amid ...

In a significant development, billionaire and philanthropist Bill Gates has said that he will donate 99% of his remaining ...

Billy Evans, Elizabeth Holmes’ longtime partner, has reportedly raised millions of dollars for a diagnostics startup that ...

The incarcerated former Silicon Valley star is advising her partner on a new health tech startup. Holmes was convicted of ...

Shares of Recursion Pharmaceuticals ( RXRX -1.48%) fell this week. The stock lost 24% as of market close on Friday. The move ...

Trump-endorsed biotech billionaire Vivek Ramaswamy won the Ohio Republican Party’s gubernatorial endorsement Friday, overcoming more experienced and potentially more popular rivals to land ...

More than 300 attendees came together to celebrate the academic success of graduating students and to honor faculty and staff ...

A South Korean biotech company is likely to benefit greatly from the policy of the U.S. Food and Drug Administration, which ...

Matthew Herper joins Adam and Allison to examine Prasad’s appointment and the band of outsiders now in charge of U.S. health ...

Angela Hwang spent nearly three decades at Pfizer before joining Flagship Pioneering in 2025 as a CEO-partner and the CEO of ...

Despite biotech's struggles, quality and global diversification create opportunities in select names. Read why portfolio ...